Atlas Trials

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

Clinical trial NCT02378753 · COMPLETED

Trial details

NCT number
NCT02378753
Sponsor
Centers for Disease Control and Prevention
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hemorrhagic Fever, Ebola
Start date
2015-04-01
Primary completion
2016-11-08
Enrollment
8651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.